European Companies Search Engine
Capital: €107.4M · Shareholder agreement · Corporate Purpose Hrb 21 Nov 2016 German Trade Register Announcements, Germany
Overview
Text
HRB 47028: Dr. Karl Thomae, GmbH, Ingelheim am
Unnamed street ??, 55216 Ingelheim a. Rhein, Germany
. The Shareholders' Meeting of November 11, 2016 decided to amend the partnership agreement in Sections 2 (object of the company) and Section 3 (share capital) and with it to increase the share capital by EUR 1,200.00 to EUR 107,401,200.00. New object of the company: acquisition and disposal, holding and management, including operational management of shareholdings and land. This includes the implementation of group-led measures of c.H. Boehringer Sohn AG & Co. KG at downstream group levels. The Company may also operate in the pharmaceutical business, in particular by developing, manufacturing and distributing chemical or pharmaceutical products itself or by entrusting others with them. New share capital: EUR 107,401,200.00.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Boehringer Ingelheim Corporate Center GmbH, Ingelheim a. Rhein, Germany.